Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Central Bank Hypnosis

One look at the chart of the U.S. financial markets against the backdrop of economic paralysis and suffering, and one is immediately filled with a myriad of emotions. Sympathy for those that have been afflicted by the most recent pandemic; fear for the families whose prim...
Streetwise Reports | June 2, 2020 |

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...
Streetwise Reports | November 7, 2019 |

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug ontheir research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account f...
Stockhouse Editorial | March 28, 2019 |

Blackrock Swings for the Fences for Gold in Nevada

I finished my latest book in January. It took another month to get the layout and a cover made just right for it. Since that time about ten thousand people have bought the book or downloaded the Kindle version for free. It is one of the highest rated books I have ever...
Streetwise Reports | September 26, 2019 |

Coronavirus China Infection Statistics Analysis, Probability Forecasts 1/2 Million Infected

We in the West are in still the CALM before the Coronavirus STORM stage, both in terms of infections and in terms of economic impact as we witness China's economy effectively grind to a halt, a harbinger of what to expect to come that the financial markets are STILL NOT disc...
Nadeem Walayat | February 24, 2020 |

Buzz on the Bullboards: Old favourites make their return

September is often seen as a “fresh start” for the markets, like a new year on the stock exchange, but this party was met with a serious hangover in the shape of poor performances among sectors that only just recently began to turn around. One ma...
Jonathon Brown | September 14, 2023 |

A steady diet of plastic

People eating fish are advised to watch carefully for bones, but how about tiny pieces of plastic? For years it has been known that plastic breaks down into microscopic particles that are consumed by shellfish, fish and mammals higher up the food chain, presentin...
Richard (Rick) Mills | August 21, 2019 |

The Power of Palladium

The StockTalk Podcast Hosts Expert Panel on Palladium & PGMs Palladium is a rare, precious metal – one of the six platinum group metals (PGMs). Its very name conjures up exotic images of a glistening, space-age metal with a price-tag that matches its scarcity. ...
Dave Jackson | October 31, 2019 |

Buzz on the Bullboards: Coronavirus, Esports, and Uranium Plays

Last week we highlighted the rise of healthcare to the top of investor’s minds in today’s climate, and the receding of interest in metals and mining. This week, we eat some of our words and highlight significant gains in both. As the COVID-1...
Omri Wallach | April 15, 2020 |

Buzz on the Bullboards: Who’s Who in the Business of COVID

(Stock photo.) It’s another week of the COVID-19 pandemic, which means another week where we see the healthcare sector continue to dominate investor attention … and for good reason. Small-cap investors are always on the lookout for the most curre...
Stockhouse Editorial | October 14, 2020 |
1 2 3 4 5 6